149 related articles for article (PubMed ID: 20702771)
1. Effects of a commonly occurring genetic polymorphism of human CYP3A4 (I118V) on the metabolism of anandamide.
Pratt-Hyatt M; Zhang H; Snider NT; Hollenberg PF
Drug Metab Dispos; 2010 Nov; 38(11):2075-82. PubMed ID: 20702771
[TBL] [Abstract][Full Text] [Related]
2. A cytochrome P450-derived epoxygenated metabolite of anandamide is a potent cannabinoid receptor 2-selective agonist.
Snider NT; Nast JA; Tesmer LA; Hollenberg PF
Mol Pharmacol; 2009 Apr; 75(4):965-72. PubMed ID: 19171674
[TBL] [Abstract][Full Text] [Related]
3. Anandamide metabolism by human liver and kidney microsomal cytochrome p450 enzymes to form hydroxyeicosatetraenoic and epoxyeicosatrienoic acid ethanolamides.
Snider NT; Kornilov AM; Kent UM; Hollenberg PF
J Pharmacol Exp Ther; 2007 May; 321(2):590-7. PubMed ID: 17272674
[TBL] [Abstract][Full Text] [Related]
4. Metabolism of Anandamide by Human Cytochrome P450 2J2 in the Reconstituted System and Human Intestinal Microsomes.
Walker VJ; Griffin AP; Hammar DK; Hollenberg PF
J Pharmacol Exp Ther; 2016 Jun; 357(3):537-44. PubMed ID: 27000802
[TBL] [Abstract][Full Text] [Related]
5. A putative 'pre-nervous' endocannabinoid system in early echinoderm development.
Buznikov GA; Nikitina LA; Bezuglov VV; Francisco ME; Boysen G; Obispo-Peak IN; Peterson RE; Weiss ER; Schuel H; Temple BR; Morrow AL; Lauder JM
Dev Neurosci; 2010 Mar; 32(1):1-18. PubMed ID: 19907129
[TBL] [Abstract][Full Text] [Related]
6. Anandamide oxidation by wild-type and polymorphically expressed CYP2B6 and CYP2D6.
Sridar C; Snider NT; Hollenberg PF
Drug Metab Dispos; 2011 May; 39(5):782-8. PubMed ID: 21289075
[TBL] [Abstract][Full Text] [Related]
7. Amino acid determinants in cyclooxygenase-2 oxygenation of the endocannabinoid anandamide.
Kozak KR; Prusakiewicz JJ; Rowlinson SW; Prudhomme DR; Marnett LJ
Biochemistry; 2003 Aug; 42(30):9041-9. PubMed ID: 12885237
[TBL] [Abstract][Full Text] [Related]
8. Effects of homologues and analogues of palmitoylethanolamide upon the inactivation of the endocannabinoid anandamide.
Jonsson KO; Vandevoorde S; Lambert DM; Tiger G; Fowler CJ
Br J Pharmacol; 2001 Aug; 133(8):1263-75. PubMed ID: 11498512
[TBL] [Abstract][Full Text] [Related]
9. Levels, metabolism, and pharmacological activity of anandamide in CB(1) cannabinoid receptor knockout mice: evidence for non-CB(1), non-CB(2) receptor-mediated actions of anandamide in mouse brain.
Di Marzo V; Breivogel CS; Tao Q; Bridgen DT; Razdan RK; Zimmer AM; Zimmer A; Martin BR
J Neurochem; 2000 Dec; 75(6):2434-44. PubMed ID: 11080195
[TBL] [Abstract][Full Text] [Related]
10. Effect of lipid rafts on Cb2 receptor signaling and 2-arachidonoyl-glycerol metabolism in human immune cells.
Bari M; Spagnuolo P; Fezza F; Oddi S; Pasquariello N; Finazzi-Agrò A; Maccarrone M
J Immunol; 2006 Oct; 177(8):4971-80. PubMed ID: 17015679
[TBL] [Abstract][Full Text] [Related]
11. Oxidation of the endogenous cannabinoid arachidonoyl ethanolamide by the cytochrome P450 monooxygenases: physiological and pharmacological implications.
Snider NT; Walker VJ; Hollenberg PF
Pharmacol Rev; 2010 Mar; 62(1):136-54. PubMed ID: 20133390
[TBL] [Abstract][Full Text] [Related]
12. Anandamide and its metabolites: what are their roles in the kidney?
Ritter JK; Li G; Xia M; Boini K
Front Biosci (Schol Ed); 2016 Jun; 8(2):264-77. PubMed ID: 27100705
[TBL] [Abstract][Full Text] [Related]
13. Oxygenated metabolites of anandamide and 2-arachidonoylglycerol: conformational analysis and interaction with cannabinoid receptors, membrane transporter, and fatty acid amide hydrolase.
van der Stelt M; van Kuik JA; Bari M; van Zadelhoff G; Leeflang BR; Veldink GA; Finazzi-Agrò A; Vliegenthart JF; Maccarrone M
J Med Chem; 2002 Aug; 45(17):3709-20. PubMed ID: 12166944
[TBL] [Abstract][Full Text] [Related]
14. The endocannabinoid anandamide is a substrate for the human polymorphic cytochrome P450 2D6.
Snider NT; Sikora MJ; Sridar C; Feuerstein TJ; Rae JM; Hollenberg PF
J Pharmacol Exp Ther; 2008 Nov; 327(2):538-45. PubMed ID: 18698000
[TBL] [Abstract][Full Text] [Related]
15. Characterisation of the cannabinoid receptor system in synovial tissue and fluid in patients with osteoarthritis and rheumatoid arthritis.
Richardson D; Pearson RG; Kurian N; Latif ML; Garle MJ; Barrett DA; Kendall DA; Scammell BE; Reeve AJ; Chapman V
Arthritis Res Ther; 2008; 10(2):R43. PubMed ID: 18416822
[TBL] [Abstract][Full Text] [Related]
16. Organized trafficking of anandamide and related lipids.
Yates ML; Barker EL
Vitam Horm; 2009; 81():25-53. PubMed ID: 19647107
[TBL] [Abstract][Full Text] [Related]
17. Characterization of anandamide-stimulated cannabinoid receptor signaling in human ULTR myometrial smooth muscle cells.
Brighton PJ; McDonald J; Taylor AH; Challiss RA; Lambert DG; Konje JC; Willets JM
Mol Endocrinol; 2009 Sep; 23(9):1415-27. PubMed ID: 19477951
[TBL] [Abstract][Full Text] [Related]
18. Modifications of the ethanolamine head in N-palmitoylethanolamine: synthesis and evaluation of new agents interfering with the metabolism of anandamide.
Vandevoorde S; Jonsson KO; Fowler CJ; Lambert DM
J Med Chem; 2003 Apr; 46(8):1440-8. PubMed ID: 12672243
[TBL] [Abstract][Full Text] [Related]
19. Human adipose tissue binds and metabolizes the endocannabinoids anandamide and 2-arachidonoylglycerol.
Spoto B; Fezza F; Parlongo G; Battista N; Sgro' E; Gasperi V; Zoccali C; Maccarrone M
Biochimie; 2006 Dec; 88(12):1889-97. PubMed ID: 16949718
[TBL] [Abstract][Full Text] [Related]
20. Anandamide down-regulates placental transporter expression through CB2 receptor-mediated inhibition of cAMP synthesis.
Szilagyi JT; Composto-Wahler GM; Joseph LB; Wang B; Rosen T; Laskin JD; Aleksunes LM
Pharmacol Res; 2019 Mar; 141():331-342. PubMed ID: 30610963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
